This is a preview of subscription content, log in via an institution to check access.
References
Abdullah-Soheimi, S.S., Lim, B.K., Hashim, O.H., and Shuib, A.S. (2010). Patients with ovarian carcinoma excrete different altered levels of urine CD59, kininogen-1 and fragments of inter-alpha-trypsin inhibitor heavy chain H4 and albumin. Proteome Sci 8, 58.
Chen, L., Li, X., Liu, L., Yu, B., Xue, Y., and Liu, Y. (2015). Erastin sensitizes glioblastoma cells to temozolomide by restraining xCT and cystathionine-γ-lyase function. Oncol Rep 33, 1465–1474.
Gao, Y.H. (2013). Urine—an untapped goldmine for biomarker discovery? Sci China Life Sci 56, 1145–1146.
Gao, Y. (2014). Roadmap to the urine biomarker era. MOJ Proteomics Bioinformatics in press doi: 10.15406/mojpb.2014.01.00005.
Giatromanolaki, A., Sivridis, E., Mitrakas, A., Kalamida, D., Zois, C.E., Haider, S., Piperidou, C., Pappa, A., Gatter, K.C., Harris, A.L., and Koukourakis, M.I. (2014). Autophagy and lysosomal related protein expression patterns in human glioblastoma. Cancer Biol Ther 15, 1468–1478.
Gollapalli, K., Ray, S., Srivastava, R., Renu, D., Singh, P., Dhali, S., Bajpai Dikshit, J., Srikanth, R., Moiyadi, A., and Srivastava, S. (2012). Investigation of serum proteome alterations in human glioblastoma multiforme. Proteomics 12, 2378–2390.
Iwadate, Y., Matsutani, T., Hirono, S., Shinozaki, N., and Saeki, N. (2016). Transforming growth factor-β and stem cell markers are highly expressed around necrotic areas in glioblastoma. J Neurooncol 129, 101–107.
Kinross, J.M., Drymousis, P., Jiménez, B., and Frilling, A. (2013). Metabonomic profiling: a novel approach in neuroendocrine neoplasias. Surgery 154, 1185–1193.
Lee, K.B., Murray, S.S., Duarte, M.E.L., Spitz, J.F., Johnson, J.S., Song, K. J., Brochmann, E.J., Taghavi, C.E., Keorochana, G., Liao, J.C., and Wang, J.C. (2011). Effects of the bone morphogenetic protein binding protein spp24 (secreted phosphoprotein 24 kD) on the growth of human lung cancer cells. J Orthop Res 29, 1712–1718.
Li, J., Song, D., Xu, Y., Huang, Z., and Yue, W. (2008). In vitro study of haematoporphyrin monomethyl ether-mediated sonodynamic effects on C6 glioma cells. Neurol Sci 29, 229–235.
Liu, M.F., Hu, Y.Y., Jin, T., Xu, K., Wang, S.H., Du, G.Z., Wu, B.L., Li, L. Y., Xu, L.Y., Li, E.M., and Xu, H.X. (2015). Matrix metalloproteinase-9/neutrophil gelatinase-associated lipocalin complex activity in human glioma samples predicts tumor presence and clinical prognosis. Dis Markers 2015, 1–7.
Louis, D.N., Ohgaki, H., Wiestler, O.D., Cavenee, W.K., Burger, P.C., Jouvet, A., Scheithauer, B.W., and Kleihues, P. (2007). The 2007 WHO classification of tumours of the central nervous system. Acta Neuropathol 114, 97–109.
Lu, J., Ksendzovsky, A., Yang, C., Mehta, G.U., Yong, R.L., Weil, R.J., Park, D.M., Mushlin, H.M., Fang, X., Balgley, B.M., Lee, D.H., Lee, C. S., Lonser, R.R., and Zhuang, Z. (2012). CNTF receptor subunit α as a marker for glioma tumor-initiating cells and tumor grade. J Neurosurg 117, 1022–1031.
Matsuura, H., and Nakazawa, S. (1985). Prognostic significance of serum alpha 1-acid glycoprotein in patients with glioblastoma multiforme: a preliminary communication.. J Neurol Neurosurg Psychiat 48, 835–837.
Osman, I., Bajorin, D.F., Sun, T.T., Zhong, H., Douglas, D., Scattergood, J., Zheng, R., Han, M., Marshall, K.W., and Liew, C.C. (2006). Novel blood biomarkers of human urinary bladder cancer. Clin Cancer Res 12, 3374–3380.
Quick, Q., and Skalli, O. (2010). α-Actinin 1 and α-actinin 4: contrasting roles in the survival, motility, and RhoA signaling of astrocytoma cells. Exp Cell Res 316, 1137–1147.
Ramírez-Expósito, M.J., Mayas-Torres, M.D., Carrera-González, M.P., Jiménez-Pulido, S.B., Illán-Cabeza, N.A., Sánchez-Sánchez, P., Hueso-Ureña, F., Martínez-Martos, J.M., and Moreno-Carretero, M.N. (2014). Silver(I)/6-hydroxyiminolumazine compounds differently modify renin–angiotensin system-regulating aminopeptidases A and N in human neuroblastoma and glioma cells. J Inorg Biochem 138, 56–63.
San-Galli, F., Vrignaud, P., Robert, J., Coindre, J.M., and Cohadon, F. (1989). Assessment of the experimental model of transplanted C6 glioblastoma in wistar rats. J Neuro Oncol 7, 299–304.
Setti, M., Osti, D., Richichi, C., Ortensi, B., Del Bene, M., Fornasari, L., Beznoussenko, G., Mironov, A., Rappa, G., Cuomo, A., Faretta, M., Bonaldi, T., Lorico, A., and Pelicci, G. (2015). Extracellular vesiclemediated transfer of CLIC1 protein is a novel mechanism for the regulation of glioblastoma growth. Oncotarget 6, 31413–31427.
Shao, C., Li, M., Li, X., Wei, L., Zhu, L., Yang, F., Jia, L., Mu, Y., Wang, J., Guo, Z., Zhang, D., Yin, J., Wang, Z., Sun, W., Zhang, Z., and Gao, Y. (2011). A tool for biomarker discovery in the urinary proteome: a manually curated human and animal urine protein biomarker database. Mol Cell Proteomics 10, M111.010975.
Wang, J.Y., and Bettegowda, C. (2015). Genetics and immunotherapy: using the genetic landscape of gliomas to inform management strategies. J Neurooncol 123, 373–383.
Zhao, M., Li, M., Li, X., Shao, C., Yin, J., and Gao, Y. (2014). Dynamic changes of urinary proteins in a focal segmental glomerulosclerosis rat model. Proteome Sci 12, 42.
Author information
Authors and Affiliations
Corresponding author
Electronic supplementary material
Rights and permissions
About this article
Cite this article
Ni, Y., Zhang, F., An, M. et al. Early candidate biomarkers found from urine of glioblastoma multiforme rat before changes in MRI. Sci. China Life Sci. 61, 982–987 (2018). https://doi.org/10.1007/s11427-017-9201-0
Received:
Accepted:
Published:
Issue Date:
DOI: https://doi.org/10.1007/s11427-017-9201-0